JP Morgan Chase’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-50,000
Closed -$487K 7065
2022
Q2
$487K Buy
+50,000
New +$487K ﹤0.01% 4587

Other funds holding SMIH

JP Morgan Chase's SMIH Position: Q3 2022 in Review

JP Morgan Chase sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q3 2022, closing a stake of 50,000 shares — an estimated $487K sold.

JP Morgan Chase first reported a position in SMIH in Q2 2022 and held it in 1 quarter. The position peaked at $487K in Q2 2022. 36 funds tracked by Wall St. Rank hold SMIH as of Q3 2022.

  • JP Morgan Chase reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Chase sold 50,000 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q3 2022, an estimated $487K.
  • JP Morgan Chase first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q2 2022 and held it in 1 quarter.
  • JP Morgan Chase's Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $487K in Q2 2022.
  • 36 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.